US4738679A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Veterinary implant
Assignee: Gene Link Australia Ltd
•
Filing: 1985-01-26
•
Granted: 1988-04-19
•
Expires: 2005-01-26
Abstract
Abstract A method of regulating the reproductive functions of animals, preferably domesticated ruminants, and veterinary implants for use in such a method are provided. The veterinary implant tablet comprises about 2-15% by weight of a fatty acid salt compression binder, about 25-50% by weight of a directly compressible vehicle selected from the group consisting of calcium phosphate and derivatives thereof, about 1-5% by weight of a granulating agent, and an amount of melatonin effective to maintain blood melatonin at, or above, a natural nighttime level of an animal to be treated for a period of time effective to accelerate an onset of breeding activity in mature animals or to delay an onset of puberty in prepubescent animals. The implant tablet provides a substantially continuous release rate of melatonin so as to maintain blood melatonin at, or above, the stated level. A method for preparing such a veterinary implant tablet is also described. A method of modifying the seasonal breeding activity of animals is also provided which comprises administering to an animal to be treated the disclosed veterinary implant tablet.
Inventors
- 👤 Robert F. Seamark
- 👤 David J. Kennaway
- 👤 Eugene Dunstan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 07:58
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K9/0024; A61K31/00; A61K31/33; A61K31/395; A61K31/40
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
155 words
A veterinary implant tablet comprising: (a) about 2 to 15% by weight based on the total weight of said tablet of a fatty acid salt compression binder; (b) about 25 to 50% by weight based on the total weight of said tablet of a directly compressible vehicle selected from the group consisting of calcium phosphate and derivatives thereof; (c) about 1 to 5% by weight based on the total weight of said tablet of a granulating agent; and (d) an amount of melatonin effective to maintain blood melatonin at, or above, a natural nighttime level of an animal to be treated for a period of time effective to accelerate an onset of breeding activity in mature animals or to delay an onset of puberty in prepubescent animals; wherein said implant tablet provides a substantially continuous release rate of melatonin so as to maintain blood melatonin at, or above, said level for said period of time.
Claim 2
Dependent Claim
155 words
A veterinary implant tablet comprising: (a) about 2 to 15% by weight based on the total weight of said tablet of a fatty acid salt compression binder; (b) about 25 to 50% by weight based on the total weight of said tablet of a directly compressible vehicle selected from the group consisting of calcium phosphate and derivatives thereof; (c) about 1 to 5% by weight based on the total weight of said tablet of a granulating agent; and (d) an amount of melatonin effective to maintain blood melatonin at, or above, a natural nighttime level of an animal to be treated for a period of time effective to accelerate an onset of breeding activity in mature animals or to delay an onset of puberty in prepubescent animals; wherein said implant tablet provides a substantially continuous release rate of melatonin so as to maintain blood melatonin at, or above, said level for said period of time.
Claim 3
Dependent Claim
32 words
The veterinary implant tablet of claim 1 wherein the blood melatonin is maintained at a level at, or above, about 100 pg/ml, and the animal to be treated is a domesticated ruminant.
Claim 4
Dependent Claim
33 words
The veterinary implant tablet of claim 1 wherein the granulating agent is selected from the group consisting of ethyl cellulose, methyl cellulose, cellulose acetate, cellulose acetate phthalate, vinyl polymers, waxes and mixtures thereof.
Claim 5
Dependent Claim
28 words
The veterinary implant tablet of claim 3 wherein the granulating agent includes a polyvinyl pyrrolidone having a molecular weight selected to provide an effective release rate of melatonin.
Claim 6
Independent Claim
186 words
A method for preparing a veterinary implant tablet which method comprises: (1) providing (a) about 2 to 15% by weight based on the total weight of said tablet of a fatty acid salt compression binder; (b) about 25 to 50% by weight based on the total weight of said tablet of a directly compressible vehicle selected from the group consisting of calcium phosphate and derivatives thereof; (c) about 1 to 5% by weight based on the total weight of said tablet of a granulating agent; and (d) an amount of melatonin effective to maintain blood melatonin at, or above, a natural nighttime level of an animal to be treated for a period of time effective to accelerate an onset of breeding activity in mature animals or to delay an onset of puberty in prepubescent animals; (2) mixing the components of step 1; and (3) compressing the mixture under a temperature and pressure sufficient to form the veterinary implant tablet; wherein said tablet provides a substantially continuous release rate of melatonin so as to maintain blood melatonin at, or above, said level for said period of time.
Claim 7
Independent Claim
186 words
A method for preparing a veterinary implant tablet which method comprises: (1) providing (a) about 2 to 15% by weight based on the total weight of said tablet of a fatty acid salt compression binder; (b) about 25 to 50% by weight based on the total weight of said tablet of a directly compressible vehicle selected from the group consisting of calcium phosphate and derivatives thereof; (c) about 1 to 5% by weight based on the total weight of said tablet of a granulating agent; and (d) an amount of melatonin effective to maintain blood melatonin at, or above, a natural nighttime level of an animal to be treated for a period of time effective to accelerate an onset of breeding activity in mature animals or to delay an onset of puberty in prepubescent animals; (2) mixing the components of step 1; and (3) compressing the mixture under a temperature and pressure sufficient to form the veterinary implant tablet; wherein said tablet provides a substantially continuous release rate of melatonin so as to maintain blood melatonin at, or above, said level for said period of time.
Claim 8
Independent Claim
174 words
A method of modifying the seasonal breeding activity of animals, which comprises administering to an animal to be treated a veterinary implant tablet comprising: (a) about 2 to 15% by weight based on the total weight of said tablet of a fatty acid salt compression binder; (b) about 25 to 50% by weight based on the total weight of said tablet of a directly compressible vehicle selected from the group consisting of calcium phosphate and derivatives thereof; (c) about 1 to 5% by weight based on the total weight of said tablet of a granulating agent; and (d) an amount of melatonin effective to maintain blood melatonin at, or above, a natural nighttime level of an animal to be treated for a period of time effective to accelerate an onset of breeding activity in mature animals or to delay an onset of puberty in prepubescent animals; wherein said implant tablet provides a substantially continuous release rate of melatonin so as to maintain blood melatonin at, or above, said level for said period of time.
Claim 9
Independent Claim
174 words
A method of modifying the seasonal breeding activity of animals, which comprises administering to an animal to be treated a veterinary implant tablet comprising: (a) about 2 to 15% by weight based on the total weight of said tablet of a fatty acid salt compression binder; (b) about 25 to 50% by weight based on the total weight of said tablet of a directly compressible vehicle selected from the group consisting of calcium phosphate and derivatives thereof; (c) about 1 to 5% by weight based on the total weight of said tablet of a granulating agent; and (d) an amount of melatonin effective to maintain blood melatonin at, or above, a natural nighttime level of an animal to be treated for a period of time effective to accelerate an onset of breeding activity in mature animals or to delay an onset of puberty in prepubescent animals; wherein said implant tablet provides a substantially continuous release rate of melatonin so as to maintain blood melatonin at, or above, said level for said period of time.
Claim 10
Dependent Claim
30 words
The method of claim 6 wherein the blood melatonin is maintained at, or above, a level of about 100 pg/ml, and the animal to be treated is a domesticated ruminant.
Claim 11
Dependent Claim
27 words
The method of claim 7 wherein the animal is a mature animal and the seasonal breeding activity is modified by accelerating the onset of the breeding season.
Claim 12
Dependent Claim
25 words
The method of claim 5 wherein the animal is a pre-pubescent animal and the seasonal breeding activity is modified by delaying the onset of puberty.
References Cited (Backward Citations)
US3428729A
Cited
FR2271832A1
Cited
US3991750A
Cited
US4322398A
Cited
US4163011A
Cited
AU5165779A
Cited
US4346709A
Cited
AU7830581A
Cited
US4576604A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-04-19 | 1991-10-19 | 1992-04-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-04-19 | 1995-10-19 | 1996-04-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-04-19 | 1999-10-19 | 2000-04-19 | $7700.00 | Window Closed / Lapsed |